Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System
Recruiting now
Conditions studied: Hypertension
In brief
This is a retrospective observational cohort study based on secondary use of routinely collected electronic health data. The design was selected to enable population-level characterisation of treatment patterns and clinical inertia (both diagnostic and therapeutic) in the management of hypertension across diverse settings in Brazil's public primary care system (SUS).
Key facts
- Study ID
- NCT07361276
- Run by
- AstraZeneca
- People needed
- 15000
- Starts
- 2026-03-31
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2026-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years at the time of Hypertension diagnosis
- Hypertension diagnosis as retrieved from registered ICD codes or CIAP Codes (primary care codes) in the EMR , OR At least two blood pressure measurements ≥140/90 mmHg during the study period. The blood measurements should be consecutive and obtained within a 30 days period.
- Continuous follow-up in the same municipality for at least 6 months after index measurement.
- Availability of structured EMR data including clinical encounters, diagnoses, and prescriptions
You may not qualify if…
- Patients with incomplete data or not traceable in the registration systems
Where it is running
- Research Site — Florianópolis, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.